Results 61 to 70 of about 665,294 (217)

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

open access: yesBreast Cancer Research, 2020
Background The tamoxifen metabolite, Z-endoxifen, demonstrated promising antitumor activity in endocrine-resistant estrogen receptor-positive (ER+) breast cancer.
Swaathi Jayaraman   +21 more
doaj   +1 more source

Biography as the Missing Variable in Drug Development: A Case for Bio‐Biographical Mechanistic Profiling

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Most clinical trial failures reflect unmeasured biological heterogeneity. Biography — chronic stress, adversity, trauma, and social isolation—is a neglected source of that heterogeneity, operating through the same molecular pathways drugs engage.
Ralph I. Horwitz
wiley   +1 more source

Building families—Implementing balanced sexual and reproductive health

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract One of the main initiatives of the World Health Organization (WHO) is the promotion of Sexual and Reproductive Health (SRH). Sexuality, infertility, and contraception are three interconnected pillars of SRH, each essential for achieving global equity in family planning and family building.
Peter Y. Liu   +9 more
wiley   +2 more sources

Sexually Dimorphic Effects of Aromatase on Neurobehavioral Responses

open access: yesFrontiers in Molecular Neuroscience, 2018
Aromatase is the enzyme responsible for converting testosterone to estradiol. In mammals, aromatase is expressed in the testes, ovaries, brain, and other tissues. While estrogen is traditionally associated with reproduction and sexual behavior in females,
Dusti A. Shay   +4 more
doaj   +1 more source

Aromatase inhibitor strategies in metastatic breast cancer

open access: yes, 2009
Heather L McArthur, Patrick G MorrisBreast Cancer Medicine Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USAAbstract: Despite ongoing therapeutic innovations, metastatic breast cancer (MBC) remains a treatable but
Patrick G Morris, Heather L McArthur
core  

Initiation of Gabapentin with Opioids and Risk of Respiratory Cardiovascular and Opioid‐Related Adverse Events Following Surgery for Breast Cancer

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Pain is a key determinant of quality‐of‐life following breast cancer surgery, the most common cancer operation in the United States. Gabapentinoids are frequently prescribed for pain management, yet their respiratory, cardiovascular, and opioid‐related adverse effects remain unclear.
Jyun‐Heng Lai   +12 more
wiley   +1 more source

Treatment Modalities for Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS): A Scoping Review of Prospective Treatment Studies [PDF]

open access: yes
Justin Andrew Bobo,1 Barbara Lubrano,2 Raul Rosario-Concepcion,3 Alejandra Cuartas-Abril,2 Pooja Advani,4 Saranya Chumsri,4,5 Barbara K Bruce2 1Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA; 2Department
Bobo JA   +6 more
core  

Creatinine–Cystatin C Discrepancy and Renal Transporter Polymorphisms in Japanese Patients with Breast Cancer Receiving Abemaciclib

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Abemaciclib increases serum creatinine by inhibiting renal tubular transporters rather than reducing true glomerular filtration rate, a phenomenon known as pseudo‐acute kidney injury. Creatinine–cystatin C discrepancy and genetic determinants of this elevation remain insufficiently characterized in Japanese patients.
Hiroaki Watanabe   +5 more
wiley   +1 more source

Steroid Sulfatase Inhibition: From Concept to Clinic and Beyond

open access: yesProceedings, 2019
Many tumours are hormone-dependent, and estrogens (E1/E2) play a key role in development.Despite aromatase inhibitor (AI) therapy [...]
Barry V L Potter
doaj   +1 more source

Sexuality in a man with aromatase deficiency

open access: yes, 1998
The evaluation of sexual behavior in a man with aromatase deficiency explains the role of estrogen on male sexuality.
Antonio R. M. Granata   +4 more
core  

Home - About - Disclaimer - Privacy